Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,capitalSurplus,totalLiab,totalStockholderEquity,deferredLongTermLiab,totalAssets,commonStock,retainedEarnings,otherLiab,treasuryStock,otherAssets,cash,totalCurrentLiabilities,shortLongTermDebt,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,longTermDebt,accountsPayable,intangibleAssets,changeToLiabilities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,changeInCash,totalCashFromOperatingActivities,depreciation,changeToNetincome,otherCashflowsFromFinancingActivities,totalCashflowsFromInvestingActivities,issuanceOfStock,capitalExpenditures,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,currency,esgPopulated,tradeable,market,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,marketState,shortName,exchange,epsTrailingTwelveMonths,exchangeDataDelayedBy,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,priceHint,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,maxAge,address1,fax,industry,address2
t0,DMSI,-4200863.0,63909000,,,-516189,,-516189,72524,0,-72524,-72524,,-101790,,,,0,0,72524,0,-443665,,-516189,-516189,33441500.0,4236111.0,-4200863.0,5804.0,35248.0,49224.0,-37704599.0,36739.0,13012.0,5804.0,22766.0,1982983.0,285143.0,13012.0,2264.0,27180.0,2216389.0,521334.0,,42780.0,50000.0,50000.0,61469.0,22200.0,-27800.0,252.0,341209.0,,,,,-1955803.0,en-US,US,EQUITY,False,Delayed Quote,0.0,1.0E-4 - 1.0E-4,0.0001,0.0,0.0,0,0,finmb_3181225,Other OTC,"Dermisonics, Inc.",USD,8991,38880,9e-05,9.0,1.0E-5 - 0.004,-0.0039000001,-0.97499996,1e-05,0.004,USD,False,False,us_market,0.0001,1630350256,0.0,0.0001,0.0001,0.0001,2500,REGULAR,DERMISONICS INC,PNK,-0.441,0,-0.085,0.0003352941,-0.00023529411,-0.7017544,0.00040330883,-0.00030330883,-0.75205106,6300,-0.0011764705,15,America/New_York,EDT,-14400000,4,-233.06,,,0.004,0.0,0.0003,0.0004,8.99k,38.88k,63.91M,,,,,,,,,,,,,,,,,,,,"Sep 29, 2006","Jun 29, 2007",0.00%,0.00%,-12.06%,-392.24%,,,,,,-22.59M,-0.4410,,22.77k,0,2.65M,,0.01,-0.09,-669.36k,97.57k,Value,92614,,"Dermisonics, Inc. manufactures ultrasonic transdermal drug-delivery technologies and equipment. It primarily focuses on the development, testing, and commercialization of its active transdermal patch, called the U-Strip, that has been designed to facilitate the needle-free delivery of drugs with large molecular structures, such as Insulin into the bloodstream. The company was formerly known as Second Stage Ventures, Inc. and changed its name to Dermisonics, Inc. in October 2004. Dermisonics, Inc. was founded in 2000 and is based in Irvine, California.",Irvine,949-733-1101,CA,1167523200,United States,86400,2 Park Plaza,949-266-8426,,Suite 450
t-1,DMSI,-5018987.0,63909000,,,-19937843,,-19937843,304103,0,-304103,-304103,,-175086,,,,0,0,304103,0,-19633740,,-19937843,-19937843,32120199.0,5078054.0,-5018987.0,48252.0,59067.0,49224.0,-37188410.0,,,48252.0,566.0,5078054.0,2867386.0,,2516.0,8299.0,,508854.0,,8433.0,25224.0,77500.0,327482.0,444.0,-77056.0,251.0,19431410.0,52276.0,,,,-5069755.0,en-US,US,EQUITY,False,Delayed Quote,0.0,1.0E-4 - 1.0E-4,0.0001,0.0,0.0,0,0,finmb_3181225,Other OTC,"Dermisonics, Inc.",USD,8991,38880,9e-05,9.0,1.0E-5 - 0.004,-0.0039000001,-0.97499996,1e-05,0.004,USD,False,False,us_market,0.0001,1630350256,0.0,0.0001,0.0001,0.0001,2500,REGULAR,DERMISONICS INC,PNK,-0.441,0,-0.085,0.0003352941,-0.00023529411,-0.7017544,0.00040330883,-0.00030330883,-0.75205106,6300,-0.0011764705,15,America/New_York,EDT,-14400000,4,-233.06,,,0.004,0.0,0.0003,0.0004,8.99k,38.88k,63.91M,,,,,,,,,,,,,,,,,,,,"Sep 29, 2006","Jun 29, 2007",0.00%,0.00%,-12.06%,-392.24%,,,,,,-22.59M,-0.4410,,22.77k,0,2.65M,,0.01,-0.09,-669.36k,97.57k,Value,92614,,"Dermisonics, Inc. manufactures ultrasonic transdermal drug-delivery technologies and equipment. It primarily focuses on the development, testing, and commercialization of its active transdermal patch, called the U-Strip, that has been designed to facilitate the needle-free delivery of drugs with large molecular structures, such as Insulin into the bloodstream. The company was formerly known as Second Stage Ventures, Inc. and changed its name to Dermisonics, Inc. in October 2004. Dermisonics, Inc. was founded in 2000 and is based in Irvine, California.",Irvine,949-733-1101,CA,1167523200,United States,86400,2 Park Plaza,949-266-8426,,Suite 450
t-2,DMSI,-4582554.0,63909000,,,-761960,,-761960,629038,0,-629038,-629038,,-132922,,,,0,0,629038,0,-132922,,-761960,-761960,32077443.0,4821372.0,14876100.0,68626.0,19697472.0,49224.0,-17250567.0,950.0,,68626.0,122.0,4805422.0,1842781.0,,2767.0,167425.0,15000.0,492323.0,19458654.0,280390.0,38706.0,38706.0,295005.0,-125948.0,-164654.0,252.0,-46909.0,52276.0,,,,-4637997.0,en-US,US,EQUITY,False,Delayed Quote,0.0,1.0E-4 - 1.0E-4,0.0001,0.0,0.0,0,0,finmb_3181225,Other OTC,"Dermisonics, Inc.",USD,8991,38880,9e-05,9.0,1.0E-5 - 0.004,-0.0039000001,-0.97499996,1e-05,0.004,USD,False,False,us_market,0.0001,1630350256,0.0,0.0001,0.0001,0.0001,2500,REGULAR,DERMISONICS INC,PNK,-0.441,0,-0.085,0.0003352941,-0.00023529411,-0.7017544,0.00040330883,-0.00030330883,-0.75205106,6300,-0.0011764705,15,America/New_York,EDT,-14400000,4,-233.06,,,0.004,0.0,0.0003,0.0004,8.99k,38.88k,63.91M,,,,,,,,,,,,,,,,,,,,"Sep 29, 2006","Jun 29, 2007",0.00%,0.00%,-12.06%,-392.24%,,,,,,-22.59M,-0.4410,,22.77k,0,2.65M,,0.01,-0.09,-669.36k,97.57k,Value,92614,,"Dermisonics, Inc. manufactures ultrasonic transdermal drug-delivery technologies and equipment. It primarily focuses on the development, testing, and commercialization of its active transdermal patch, called the U-Strip, that has been designed to facilitate the needle-free delivery of drugs with large molecular structures, such as Insulin into the bloodstream. The company was formerly known as Second Stage Ventures, Inc. and changed its name to Dermisonics, Inc. in October 2004. Dermisonics, Inc. was founded in 2000 and is based in Irvine, California.",Irvine,949-733-1101,CA,1167523200,United States,86400,2 Park Plaza,949-266-8426,,Suite 450
t-3,DMSI,-3841987.0,63909000,,,-1376143,,-1376143,979274,0,-979274,-979274,,-164042,,,,0,0,979274,0,-396869,,-1376143,-1376143,32056050.0,4467013.0,15616667.0,89000.0,20083680.0,48473.0,-16488607.0,61672.0,751.0,89000.0,126070.0,3899909.0,2558643.0,751.0,3019.0,533007.0,505432.0,383083.0,19458654.0,65647.0,1834.0,528934.0,613072.0,126070.0,-399845.0,252.0,128344.0,278201.0,-3019.0,248899.0,-3019.0,-3366902.0,en-US,US,EQUITY,False,Delayed Quote,0.0,1.0E-4 - 1.0E-4,0.0001,0.0,0.0,0,0,finmb_3181225,Other OTC,"Dermisonics, Inc.",USD,8991,38880,9e-05,9.0,1.0E-5 - 0.004,-0.0039000001,-0.97499996,1e-05,0.004,USD,False,False,us_market,0.0001,1630350256,0.0,0.0001,0.0001,0.0001,2500,REGULAR,DERMISONICS INC,PNK,-0.441,0,-0.085,0.0003352941,-0.00023529411,-0.7017544,0.00040330883,-0.00030330883,-0.75205106,6300,-0.0011764705,15,America/New_York,EDT,-14400000,4,-233.06,,,0.004,0.0,0.0003,0.0004,8.99k,38.88k,63.91M,,,,,,,,,,,,,,,,,,,,"Sep 29, 2006","Jun 29, 2007",0.00%,0.00%,-12.06%,-392.24%,,,,,,-22.59M,-0.4410,,22.77k,0,2.65M,,0.01,-0.09,-669.36k,97.57k,Value,92614,,"Dermisonics, Inc. manufactures ultrasonic transdermal drug-delivery technologies and equipment. It primarily focuses on the development, testing, and commercialization of its active transdermal patch, called the U-Strip, that has been designed to facilitate the needle-free delivery of drugs with large molecular structures, such as Insulin into the bloodstream. The company was formerly known as Second Stage Ventures, Inc. and changed its name to Dermisonics, Inc. in October 2004. Dermisonics, Inc. was founded in 2000 and is based in Irvine, California.",Irvine,949-733-1101,CA,1167523200,United States,86400,2 Park Plaza,949-266-8426,,Suite 450
